This company has shut down. TSG Therapeutics is no longer operating — its last tracked round was a Corporate Round in 2023.
Explore the Startup GraveyardTSG Therapeutics is a preclinical-stage biopharmaceutical firm dedicated to the abolition of viral infectious illness.
TSG Therapeutics has raised $1.6M in total funding. The most recent round was Corporate Round. The last funding was announced in January 2023.
TSG Therapeutics's investors include SparkLabs Accelerator, Daehan New Pharm.
TSG Therapeutics is headquartered in Singapore, Singapore.
TSG Therapeutics is a preclinical-stage biopharmaceutical firm dedicated to the abolition of viral infectious illness.
TSG Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TSG Therapeutics — Funding & Investors." VCBacked, January 3, 2023, https://www.vcbacked.co/company/tsg-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). TSG Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tsg-therapeutics
{{cite web |title=TSG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tsg-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated